Tag : Monoclonal Antibody

Neurology

CGRPs Promising for Prevention of Chronic Cluster Headache

Newsemia
Treatment with CGRP monoclonal antibodies may reduce the frequency of chronic cluster headache attacks in patients with an inadequate response to other preventive medications, new...
Latest News

Targeted treatment for systemic lupus erythematosus

Newsemia
A team of researchers from Charité – Universitätsmedizin Berlin and the Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, have successfully treated two patients with the autoimmune...
Neurology

B Cell Test Predicts Alemtuzumab Autoimmunity in MS

Newsemia
Analyzing B cell counts before treatment could help select patients for the drug, a new study suggests. Medscape Medical News Source link...
Neurology

In MS, Serious AEs More Common in Rituximab vs Ocrelizumab

Newsemia
Medscape Medical News Source link...
Neurology

Lowering Rituximab Dose in Patients With MS Safe, Effective

Newsemia
A new study has found that reducing rituximab dosage from 1,000 mg every 6 months to 500 mg every 6 months is a safe and...
Latest News

UChicago Medicine launches clinical trial to test the potential of antibody against SARS-CoV-2

Newsemia
The University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19,...
Neurology

Negative Phase 2 Trial Data Ends Development of PSP Drug

Newsemia
Phase 2 trial results show gosuranemab did not meet primary or key secondary endpoints in patients with progressive supranuclear palsy, leading to discontinuation of the...
Neurology

PREVENT: Eculizumab May Lower Relapse Risk in NMOSD

Newsemia
Use of eculizumab resulted in significantly greater relapse reduction over placebo in patients with neuromyelitis optica spectrum disorder (NMSOD), new findings from the phase 3...
Neurology

Anti-CGRP Monoclonal Antibodies for Migraine Prevention

Newsemia
Dr Deborah Friedman reviews the new anti-CGRP monoclonal antibodies for migraine prevention. American Headache Society and Medscape Source link...
Neurology

Novel Anti-B-Cell Therapy Looks Promising in MS

Newsemia
A new and novel oral therapy for multiple sclerosis, which inactivates rather than depletes B cells, has shown promising results in its first efficacy study....
Latest News

Antibody Screening Tools; Improving Workflows

Newsemia
Antibody screening tools have exponentially increased the rate that candidates can be screened, multiplexing will increase processing to thousands per hour.¬ Source link...
Latest News

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Newsemia
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen...
Latest News

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Newsemia
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AJOVY injection for the preventive treatment of migraine in adults....
Latest News

New project aims to combat drug-resistant bacteria in hospitals

Newsemia
Antibiotic resistance is a big global public health problem. Of particular concern are multidrug-resistant Gram-negative bacteria, which are among the leading causes of serious, debilitating...
Latest News

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Newsemia
Omeros Corporation announced today that the European Medicines Agency’s Committee for Orphan Medicinal Products issued a positive opinion recommending orphan drug designation of OMS721 for...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World